SLC37A4 rs193302889: Understanding Glycogen Storage Disease Type Ib
The rs193302889 variant is a specific genetic change located within the SLC37A4 gene. This variant is associated with Glycogen Storage Disease Type Ib (GSDIb), a rare metabolic disorder that affects how the body processes glucose.
What each genotype means
Typical genetic profile
This is the most common genotype observed in the general population for this location in the SLC37A4 gene. It is considered the reference sequence and is not associated with the specific clinical conditions linked to rare variants in this gene.
This is the predominant genotype found in the vast majority of individuals across all global populations.
Carrier of rare variant
This genotype indicates that one copy of the gene carries the A allele, which is a rare variant. While the SLC37A4 gene is associated with glycogen storage disease type Ib, this condition typically follows an autosomal recessive inheritance pattern, meaning carriers are generally asymptomatic.
This genotype is rare and observed at very low frequencies in global population databases.
Potential clinical significance
This genotype indicates that both copies of the gene carry the rare A allele. Research associates certain rare variants in SLC37A4 with glycogen storage disease type Ib, which can involve metabolic and ocular complications; however, the clinical interpretation of this specific variant requires professional medical evaluation and family segregation studies to confirm its impact.
This genotype is extremely rare in the general population.
Understanding the SLC37A4 Gene
The SLC37A4 gene provides instructions for creating a protein known as the glucose-6-phosphate transporter. This protein is essential for the normal function of cells, particularly in the liver and kidneys. Its primary role is to transport glucose-6-phosphate into the endoplasmic reticulum, where it can be broken down into glucose and released into the bloodstream to maintain healthy blood sugar levels. When the SLC37A4 gene contains pathogenic variants, the transporter protein may not function correctly. This disruption prevents the body from effectively releasing stored energy, leading to the accumulation of glycogen and fat in organs. This underlying mechanism is the hallmark of Glycogen Storage Disease Type Ib, a condition that can manifest with various clinical symptoms, including hepatomegaly, nephromegaly, and issues related to neutrophil function.
The Role of rs193302889 in GSDIb
The variant rs193302889 is identified in the context of GSDIb, an autosomal recessive disorder. In genetics, autosomal recessive conditions typically require an individual to inherit two copies of a pathogenic variant—one from each parent—to manifest the clinical symptoms of the disease. Research into SLC37A4 has identified over 100 different variants that can contribute to this condition. While some variants are more common in specific populations, others are extremely rare. The evidence linking specific variants like rs193302889 to GSDIb is based on clinical observations of individuals presenting with metabolic symptoms. Because GSDIb is an ultrarare disorder, the clinical impact of any single variant is often studied through case reports and small cohort studies. It is important to note that the presence of a variant does not automatically guarantee a specific clinical outcome, as the severity of GSDIb can vary significantly between individuals.
Navigating Genetic Information
If you or a family member have been identified as a carrier of an SLC37A4 variant, it is essential to consult with a healthcare professional, such as a genetic counselor or a metabolic specialist. Genetic information is complex, and clinical diagnosis requires more than just identifying a single SNP; it involves a comprehensive review of medical history, physical symptoms, and biochemical testing. You cannot diagnose a condition based solely on a genetic report. Furthermore, treatments for GSDIb, such as the use of SGLT2 inhibitors like empagliflozin for neutrophil dysfunction, must be managed exclusively by a qualified clinician. Never attempt to self-diagnose or alter medical treatments based on genetic data. A clinical geneticist can provide context regarding the significance of your specific results and guide you through the appropriate diagnostic or management steps tailored to your unique health profile.
How common is this variant?
The rs193302889 variant is considered rare in the general population. Specific frequency data varies by ancestry, and it is most frequently identified in clinical settings involving patients already suspected of having GSDIb.
Frequently asked questions
What is Glycogen Storage Disease Type Ib?
GSDIb is a rare inherited metabolic disorder caused by mutations in the SLC37A4 gene. It prevents the body from properly breaking down glycogen into glucose, which can lead to low blood sugar and other complications.
Is rs193302889 a diagnosis for GSDIb?
No, a single SNP result is not a diagnosis. A clinical diagnosis of GSDIb requires a combination of genetic testing, biochemical analysis, and a physical examination by a medical specialist.
Can I treat GSDIb with supplements?
There is no evidence that supplements can treat GSDIb. Management of this condition is complex and must be overseen by a metabolic specialist, often involving specific dietary protocols and medications.
Where can I find more information on SLC37A4?
You can find reliable information on the SLC37A4 gene through resources like MedlinePlus Genetics or the NCBI Gene database. Always discuss these findings with your doctor.
Sources & further reading
Educational information only, last refreshed 10/17/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs193302889?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29